MG
Michael David Garrison
EVP & Pres Med.Essntl&BioPharm

Michael David Garrison insider trades: Becton Dickinson (BDX) stock sales

EVP & Pres Med.Essntl&BioPharm, Becton Dickinson Last trade Jun 10, 2026 17 Form 4 filings
$624K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 10, 2026BDX↓ Sell$167K
Jan 15, 2026BDX↓ Sell$334K
Dec 17, 2025BDX↓ Sell$123K
Jul 18, 2025BDX↓ Sell$214K
Apr 9, 2025BDX↓ Sell$94K
Jan 17, 2025BDX↓ Sell$141K
Dec 19, 2024BDX↓ Sell$634K
Apr 30, 2024BDX↓ Sell$399K
Dec 11, 2023BDX↓ Sell$288K
Aug 8, 2023BDX↓ Sell$360K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BDX insiders

Open-market trades in the last 12 months

About Michael David Garrison's insider trades

Michael David Garrison is EVP & Pres Med.Essntl&BioPharm at Becton Dickinson (BDX). Since Aug 8, 2023, Michael has reported no open-market purchases and 10 sales worth $2.8M on SEC Form 4. In the last 12 months: 3 sales ($624K).

Their filings also include shares withheld for taxes (7 filings), grants and awards (4 filings), option exercises (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.